Fas gene mutation in the progression of adult T cell leukemia

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1063-1071

  Maeda, Takahiro ^a,b   Yamada, Yasuaki ^b   Moriuchi, Ryozou ^b   Sugahara, Kazuyuki ^b   Tsuruda, Kazuto ^b   Joh, Tatsurou ^c   Atogami, Sunao ^a   Tsukasaki, Kunihiro ^a   Tomonaga, Masao ^a   Kamihira, Shimeru ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Adult T cell leukemia; Apoptosis; CD95; Death domain; Human T lymphotropic virus type I

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CASE REPORT; CELL KILLING; CROSS LINKING; GENE MUTATION; HUMAN; HYPERGAMMAGLOBULINEMIA; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; STOP CODON; T CELL LEUKEMIA;

AGED; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; ASCITES; BASE SEQUENCE; DISEASE PROGRESSION; EXONS; FATAL OUTCOME; FRAMESHIFT MUTATION; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULIN M; JURKAT CELLS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LYMPH NODES; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM CIRCULATING CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033526084     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1063     Document Type: Article

References (50)

1. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
2. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932-10937.
3. Cheng, J., T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, P.J. Barr, and J.D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1759-1762.
4. Cascino, I., G. Fiucci, G. Papoff, and G. Ruberti. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:2706-2713.
5. Papoff, G., I. Cascino, A. Eramo, G. Starace, D.H. Lynch, and G. Ruberti. 1996. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol. 156:4622-4630.
6. Lynch, D.H., F. Ramsdell, and M.R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:569-574.
7. Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355-365.
8. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferacion disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314-317.
9. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1756-1760.
10. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
11. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946.
12. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I.A. Roberts, K.M. Debatin, A. Fischer, and J.P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 268:1347-1349.
13. Bettinardi, A., D. Brugnoni, E. Quiros-Roldan, A. Malagoli, S. La Grutta, A. Correra, and L.D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood. 89:902-909.
14. Drappa, J., A.K. Vaishnaw, K.E. Sullivan, J.L. Chu, and K.B. Elkon. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643-1649.
15. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 50:481-492.
16. Yamada, Y. 1983. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood. 61:192-199.
17. Poiesz, B.J., F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, and R.C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:7415-7419.
18. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K.I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA. 78:6476-6480.
19. Yoshida, M., M. Seiki, K. Yamaguchi, and K. Takatsuki. 1984. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA. 81:2534-2537.
20. Shimoyama, M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79:428-437.
21. Shimoyama, M., K. Ota, M. Kikuchi, K. Yunoki, S. Konda, K. Takatsuki, M. Ichimaru, M. Ogawa, I. Kimura, S. Tominaga, et al. 1988. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J. Clin. Oncol. 6:128-141.
22. Debatin, K.M., C.K. Goldmann, R. Bamford, T.A. Waldmann, and P.H. Krammer. 1990. Monoclonal-antibody-mediated apoptosis in adult T cell leukaemia. Lancet. 335: 497-500.
23. Debatin, K.M., C.K. Goldman, T.A. Waldmann, and P.H. Krammer. 1993. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. 81:2972-2977.
24. Sugahara, K., Y. Yamada, Y. Hiragata, Y. Matsuo, K. Tsuruda, M. Tomonaga, T. Maeda, S. Atogami, K. Tsukasaki, and S. Kamihira. 1997. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines. Int. J. Cancer. 72:128-132.
25. Kamihira, S., Y. Yamada, Y. Hirakata, K. Tsuruda, K. Sugahara, M. Tomonaga, T. Maeda, K. Tsukasaki, S. Atogami, and N. Kobayashi. 1997. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias. Br. J. Haematol. 99:858-865.
26. Landowski, T.H., N. Qu, I. Buyuksal, J.S. Painter, and W.S. Dalton. 1997. Mutations in the Fas antigen in patients with multiple myeloma. Blood. 90:4266-4270.
27. Beltinger, C., E. Kurz, T. Bohler, M. Schrappe, W.D. Ludwig, and K.M. Debatin. 1998. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood. 91:3943-3951.
28. Tamiya, S., K. Etoh, H. Suzushima, K. Takatsuki, and M. Matsuoka. 1998. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood. 91:3935-3942.
29. Yamada, Y., M. Fujita, H. Suzuki, S. Atogami, H. Sohda, K. Murata, K. Tsukasaki, S. Momita, T. Kohno, T. Maeda, et al. 1994. Established IL-2-dependent double-negative (CD4-CD8-) TCR alpha beta/CD3+ ATL cells: induction of CD4 expression. Br. J. Haematol. 88:234-241.
30. Yamada, Y., Y. Ohmoto, T. Hata, M. Yamamura, K. Murata, K. Tsukasaki, T. Kohno, Y. Chen, S. Kamihira, and M. Tomonaga. 1996. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk. Lymphoma. 21:443-447.
31. Kamihira, S., H. Sohda, S. Atogami, K. Toriya, Y. Yamada, K. Tsukazaki, S. Momita, S. Ikeda, M. Kusano, T. Amagasaki, et al. 1992. Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk. Res. 16:435-441.
32. Tsukasaki, K., S. Ikeda, K. Murata, T. Maeda, S. Atogami, H. Sohda, S. Momita, T. Jubashi, Y. Yamada, M. Mine, et al. 1993. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk. Res. 17:157-166.
33. Kotani, T., Y. Aratake, S. Kondo, K. Tamura, and S. Ohtaki. 1994. Expression of functional Fas antigen on adult T-cell leukemia. Leuk. Res. 18:305-310.
34. Kamihira, S., Y. Yamada, Y. Hiragata, T. Yamaguchi, K. Izumikawa, Y. Matsuo, K. Sugahara, K. Tsuruta, S. Atogami, K. Tsukasaki, et al. 1997. Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases. Intern. Med. 36:166-170.
35. Xerri, L., N. Carbuccia, P. Parc, and F. Birg. 1995. Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas. Am. J. Clin. Pathol. 104:424-430.
36. Basu, A., M. Raghunath, S. Bishayee, and M. Das. 1989. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9:671-677.
37. Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454-1463.
38. Amaya, E., T.J. Musci, and M.W. Kirschner. 1991. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell. 66: 257-270.
39. Ueno, H., M. Gunn, K. Dell, A. Tseng, Jr., and L. Williams. 1992. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem. 267:1470-1476.
40. Li, Y., C. Basilico, and A. Mansukhani. 1994. Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol. 14:7660-7669.
41. Ueno, H., H. Colbert, J.A. Escobedo, and L.T. Williams. 1991. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor. Science. 252:844-848.
42. Banner, D.W., A. D'Arcy, W. Janes, R. Gentz, H.J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 73:431-445.
43. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1129-1135.
44. Kischkel, F.C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter. 1995. Cytotoxicity-dependent APO 1(Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579-5588.
45. Okamoto, T., Y. Ohno, S. Tsugane, S. Watanabe, M. Shimoyama, K. Tajima, M. Miwa, and K. Shimotohno. 1989. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn. J. Cancer Res. 80:191-195.
46. Sakashita, A., T. Hattori, C.W. Miller, H. Suzushima, N. Asou, K. Takatsuki, and H.P. Koeffler. 1992. Mutations of the p53 gene in adult T cell leukemia. Blood. 79:477-480.
47. Hatta, Y., T. Hirama, C.W. Miller, Y. Yamada, M. Tomonaga, and H.P. Koeffler. 1995. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood. 85:2699-2704.
48. Yamada, Y., Y. Hatta, K. Murata, K. Sugawara, S. Ikeda, M. Mine, T. Maeda, Y. Hirakata, S. Kamihira, K. Tsukasaki, et al. 1997. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J. Clin. Oncol. 15:1778-1785.
49. Zornig, M., A. Grzeschiczek, M.B. Kowalski, K.U. Hartmann, and T. Moroy. 1995. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene. 10: 2397-2401.
50. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149-1154.